Family planning leaders and implementers can draw from an established evidence base to integrate DMPA-SC in efforts to address unmet need and increase access to contraception through a range of delivery channels.
Based on growing demand among stakeholders, providers, and family planning clients, as well as increased investment from the donor community, countries across sub-Saharan Africa and Asia are pursuing introduction and scale-up of DMPA-SC and self-injection. Through these country experiences, partners have generated evidence and practical guidance for ministries of health, nongovernmental implementing partners, and policymakers working to introduce and scale up DMPA-SC or similar products.
The Family Planning Financing Roadmap is a resource for USAID Mission staff and others working on family planning issues in developing countries. The website is designed to support sustainable family planning approaches for a wide range of users, from those who have very limited knowledge of health financing concepts to those who have some knowledge or experience and are looking to develop a deeper understanding of specific issues. The website has three main sections: learning materials, an interactive roadmap, and a community of practice.
The Reproductive Health Supplies Visualizer (RH Viz) is a series of public-facing dashboards designed to help the RH community see integrated and aggregated supply chain inventory, order, and shipment data.
The Global Family Planning Visibility and Analytics Network (VAN) captures data from multiple sources to improve supply chain visibility. The VAN offers a platform to assess supply needs, prioritize them, and act when supply imbalances loom.
The DMPA-SC Access Collaborative provides data-driven technical assistance, resources, and tools that countries need for designing, implementing, and monitoring the introduction and scale up of DMPA-SC self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming.
In addition to general information and evidence on DMPA-SC, partners can access the support outlined in the menu by submitting a request through the technical assistance request form linked below. Your request can be submitted by emailing the completed form to FPoptions@path.org.
Institutional Author(s): PATH, JSI, Inc.
Publication date: December, 2020
This toolkit contains resources designed to help pharmacy associations become effective advocates and begin working to change policies in their countries. The toolkit can be adapted to advocate for any injectable contraceptive. The toolkit includes a Resource for Considering DMPA-SC.
This comprehensive toolkit is intended for agencies and organizations working to plan, implement, evaluate, promote, and scale up community-based access to injectables programs and to advocate for changes to national policy and service delivery guidelines.
This is a practical reference for global health practitioners working to introduce or scale up medical devices, diagnostics, or other consumer products. Its four-stage model uses case studies to highlight lessons and factors for consideration. Includes a practitioner’s workbook and a toolkit.
This brief outlines how, when appropriately designed and implemented, community health worker programs can increase use of contraception, particularly where unmet need is high, access is low, and geographic or social barriers to use of services exist. The brief describes the importance of community-based family planning programs as a means of reducing inequities in access to services and outlines key issues for planning and implementation.